Compile Data Set for Download or QSAR
maximum 50k data
Found 41 Enz. Inhib. hit(s) with all data for entry = 9939
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM501527(US11026958, Example 1 | US11026958, Example A2)
Affinity DataEC50:  500nMAssay Description:Test compounds were serially diluted in DMSO and then resuspended to the final test concentration in external recording solution, with, or without 40...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM501622(US11026958, Example G5)
Affinity DataEC50:  3.40E+3nMAssay Description:Test compounds were serially diluted in DMSO and then resuspended to the final test concentration in external recording solution, with, or without 40...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM501584(US11026958, Example 3)
Affinity DataEC50:  1.50E+3nMAssay Description:Test compounds were serially diluted in DMSO and then resuspended to the final test concentration in external recording solution, with, or without 40...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM501585(US11026958, Example 4 | US11026958, Example A13)
Affinity DataEC50:  1.00E+3nMAssay Description:Test compounds were serially diluted in DMSO and then resuspended to the final test concentration in external recording solution, with, or without 40...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM501586(US11026958, Example 5 | US11026958, Example C3)
Affinity DataEC50:  410nMAssay Description:Test compounds were serially diluted in DMSO and then resuspended to the final test concentration in external recording solution, with, or without 40...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM501587(US11026958, Example 6)
Affinity DataEC50:  720nMAssay Description:Test compounds were serially diluted in DMSO and then resuspended to the final test concentration in external recording solution, with, or without 40...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM501588(US11026958, Example 7)
Affinity DataEC50:  320nMAssay Description:Test compounds were serially diluted in DMSO and then resuspended to the final test concentration in external recording solution, with, or without 40...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM501589(US11026958, Example 8)
Affinity DataEC50:  1.20E+3nMAssay Description:Test compounds were serially diluted in DMSO and then resuspended to the final test concentration in external recording solution, with, or without 40...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM501590(US11026958, Example 9)
Affinity DataEC50:  1.40E+3nMAssay Description:Test compounds were serially diluted in DMSO and then resuspended to the final test concentration in external recording solution, with, or without 40...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM501591(US11026958, Example 10)
Affinity DataEC50:  210nMAssay Description:Test compounds were serially diluted in DMSO and then resuspended to the final test concentration in external recording solution, with, or without 40...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM501592(US11026958, Example 11 | US11026958, Example C5)
Affinity DataEC50:  240nMAssay Description:Test compounds were serially diluted in DMSO and then resuspended to the final test concentration in external recording solution, with, or without 40...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM501527(US11026958, Example 1 | US11026958, Example A2)
Affinity DataEC50:  410nMAssay Description:Test compounds were serially diluted in DMSO and then resuspended to the final test concentration in external recording solution, with, or without 40...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM501594(US11026958, Example A11 | US11026958, Example A3)
Affinity DataEC50:  550nMAssay Description:Test compounds were serially diluted in DMSO and then resuspended to the final test concentration in external recording solution, with, or without 40...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM501595(US11026958, Example A6)
Affinity DataEC50:  700nMAssay Description:Test compounds were serially diluted in DMSO and then resuspended to the final test concentration in external recording solution, with, or without 40...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM501596(US11026958, Example A7)
Affinity DataEC50:  2.40E+3nMAssay Description:Test compounds were serially diluted in DMSO and then resuspended to the final test concentration in external recording solution, with, or without 40...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM501597(US11026958, Example A8)
Affinity DataEC50:  3.30E+3nMAssay Description:Test compounds were serially diluted in DMSO and then resuspended to the final test concentration in external recording solution, with, or without 40...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM501598(US11026958, Example A9)
Affinity DataEC50:  5.60E+3nMAssay Description:Test compounds were serially diluted in DMSO and then resuspended to the final test concentration in external recording solution, with, or without 40...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM501594(US11026958, Example A11 | US11026958, Example A3)
Affinity DataEC50:  460nMAssay Description:Test compounds were serially diluted in DMSO and then resuspended to the final test concentration in external recording solution, with, or without 40...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM501585(US11026958, Example 4 | US11026958, Example A13)
Affinity DataEC50:  1.50E+3nMAssay Description:Test compounds were serially diluted in DMSO and then resuspended to the final test concentration in external recording solution, with, or without 40...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM501601(US11026958, Example B1)
Affinity DataEC50:  1.60E+3nMAssay Description:Test compounds were serially diluted in DMSO and then resuspended to the final test concentration in external recording solution, with, or without 40...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM501602(US11026958, Example B2)
Affinity DataEC50:  8.80E+3nMAssay Description:Test compounds were serially diluted in DMSO and then resuspended to the final test concentration in external recording solution, with, or without 40...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM501603(US11026958, Example C1)
Affinity DataEC50:  280nMAssay Description:Test compounds were serially diluted in DMSO and then resuspended to the final test concentration in external recording solution, with, or without 40...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM501586(US11026958, Example 5 | US11026958, Example C3)
Affinity DataEC50:  1.80E+3nMAssay Description:Test compounds were serially diluted in DMSO and then resuspended to the final test concentration in external recording solution, with, or without 40...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM501605(US11026958, Example C4)
Affinity DataEC50:  1.90E+3nMAssay Description:Test compounds were serially diluted in DMSO and then resuspended to the final test concentration in external recording solution, with, or without 40...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM501592(US11026958, Example 11 | US11026958, Example C5)
Affinity DataEC50:  3.30E+3nMAssay Description:Test compounds were serially diluted in DMSO and then resuspended to the final test concentration in external recording solution, with, or without 40...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM501607(US11026958, Example C6)
Affinity DataEC50:  1.60E+3nMAssay Description:Test compounds were serially diluted in DMSO and then resuspended to the final test concentration in external recording solution, with, or without 40...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM501608(US11026958, Example D1)
Affinity DataEC50:  2.90E+3nMAssay Description:Test compounds were serially diluted in DMSO and then resuspended to the final test concentration in external recording solution, with, or without 40...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM501609(US11026958, Example D2)
Affinity DataEC50:  2.20E+3nMAssay Description:Test compounds were serially diluted in DMSO and then resuspended to the final test concentration in external recording solution, with, or without 40...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM501610(US11026958, Example D4)
Affinity DataEC50:  720nMAssay Description:Test compounds were serially diluted in DMSO and then resuspended to the final test concentration in external recording solution, with, or without 40...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM501611(US11026958, Example D5)
Affinity DataEC50:  1.80E+3nMAssay Description:Test compounds were serially diluted in DMSO and then resuspended to the final test concentration in external recording solution, with, or without 40...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM501612(US11026958, Example D7)
Affinity DataEC50:  900nMAssay Description:Test compounds were serially diluted in DMSO and then resuspended to the final test concentration in external recording solution, with, or without 40...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM501613(US11026958, Example D8)
Affinity DataEC50:  3.80E+3nMAssay Description:Test compounds were serially diluted in DMSO and then resuspended to the final test concentration in external recording solution, with, or without 40...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM501614(US11026958, Example D10)
Affinity DataEC50:  1.10E+3nMAssay Description:Test compounds were serially diluted in DMSO and then resuspended to the final test concentration in external recording solution, with, or without 40...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM501615(US11026958, Example D11)
Affinity DataEC50:  3.30E+3nMAssay Description:Test compounds were serially diluted in DMSO and then resuspended to the final test concentration in external recording solution, with, or without 40...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM501616(US11026958, Example E3)
Affinity DataEC50:  500nMAssay Description:Test compounds were serially diluted in DMSO and then resuspended to the final test concentration in external recording solution, with, or without 40...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM501617(US11026958, Example F1)
Affinity DataEC50:  3.70E+3nMAssay Description:Test compounds were serially diluted in DMSO and then resuspended to the final test concentration in external recording solution, with, or without 40...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM501618(US11026958, Example F2)
Affinity DataEC50:  5.20E+3nMAssay Description:Test compounds were serially diluted in DMSO and then resuspended to the final test concentration in external recording solution, with, or without 40...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM501619(US11026958, Example G2)
Affinity DataEC50:  3.20E+3nMAssay Description:Test compounds were serially diluted in DMSO and then resuspended to the final test concentration in external recording solution, with, or without 40...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM501620(US11026958, Example G3)
Affinity DataEC50:  870nMAssay Description:Test compounds were serially diluted in DMSO and then resuspended to the final test concentration in external recording solution, with, or without 40...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM501621(US11026958, Example G4)
Affinity DataEC50:  1.00E+3nMAssay Description:Test compounds were serially diluted in DMSO and then resuspended to the final test concentration in external recording solution, with, or without 40...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM501583(US11026958, Example 2)
Affinity DataEC50:  2.00E+3nMAssay Description:Test compounds were serially diluted in DMSO and then resuspended to the final test concentration in external recording solution, with, or without 40...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent